Sanjay Singhal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sanjay Singhal has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Krupal Joshi
Department of Community and Family Medicine, AIIMS, Rajkot, Gujarat, India
7 shared publications Kunal Deokar
Department of Pulmonary Medicine, All India Institute of Medical Sciences, Rajkot, Gujarat, India
7 shared publications- Mohan Gurjar
Department of Critical Care Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India
7 shared publications - Ravindra Kumar Garg
Department of Neurology, Era’s Lucknow Medical College & Hospital, Lucknow, India
7 shared publications Aneri Parekh
Department of Pulmonary Medicine, All India Institute of Medical Sciences, Rajkot, Gujarat, India
5 shared publications- Ashwani Tandon
Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
5 shared publications
Latest Publications
- 9 November 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis
Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis
- 9 November 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis
Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis
- Open Access
- 3 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7668
Heterogeneity in Self-Reported Management of Blunt Chest Trauma: An International Cross-Sectional Survey
Background: Blunt chest trauma is common, but reported management practices may differ across clinical settings. This international cross-sectional survey evaluated self-reported practice patterns in the diagnosis and management of blunt chest trauma. Methods: We distributed a self-administered web-based questionnaire to healthcare professionals involved in chest trauma care between November 2024 and August 2025. Responses were analyzed descriptively, and exploratory comparisons were performed between Italian respondents and respondents from other participating countries. Results: A total of 509 responses were included, comprising 225 Italian and 284 international respondents. Within the participating sample, differences between Italian respondents and respondents from other participating countries were observed in institutional protocol availability, diagnostic imaging choices, pain management organization, adjunctive therapies, and factors guiding rib-fracture management. Greater consistency was observed in chest tube placement and escalation of respiratory support. Conclusions: Substantial heterogeneity in self-reported blunt chest trauma management was observed among participating clinicians, particularly regarding institutional protocols, diagnostic strategies, pain management, adjunctive therapies, and rib-fracture management. Greater consistency was observed in core interventions such as chest tube placement and escalation of respiratory support. Given the voluntary sampling strategy and unequal geographic representation, these findings should be interpreted as patterns within the participating sample rather than as representative estimates of national or global practice.
- 3 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7668
Open AccessHeterogeneity in Self-Reported Management of Blunt Chest Trauma: An International Cross-Sectional Survey
Background: Blunt chest trauma is common, but reported management practices may differ across clinical settings. This international cross-sectional survey evaluated self-reported practice patterns in the diagnosis and management of blunt chest trauma. Methods: We distributed a self-administered web-based questionnaire to healthcare professionals involved in chest trauma care between November 2024 and August 2025. Responses were analyzed descriptively, and exploratory comparisons were performed between Italian respondents and respondents from other participating countries. Results: A total of 509 responses were included, comprising 225 Italian and 284 international respondents. Within the participating sample, differences between Italian respondents and respondents from other participating countries were observed in institutional protocol availability, diagnostic imaging choices, pain management organization, adjunctive therapies, and factors guiding rib-fracture management. Greater consistency was observed in chest tube placement and escalation of respiratory support. Conclusions: Substantial heterogeneity in self-reported blunt chest trauma management was observed among participating clinicians, particularly regarding institutional protocols, diagnostic strategies, pain management, adjunctive therapies, and rib-fracture management. Greater consistency was observed in core interventions such as chest tube placement and escalation of respiratory support. Given the voluntary sampling strategy and unequal geographic representation, these findings should be interpreted as patterns within the participating sample rather than as representative estimates of national or global practice.
- Open Access
- 1 July 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 89 (3) , 416-425
Linezolid-Induced Optic Neuritis in Tuberculosis: A Systematic Review of Case Reports, Case Series, and Cohort Studies
Background: With the increasing use of linezolid for the treatment of drug-resistant tuberculosis, concerns have emerged regarding serious adverse effects, including optic neuritis. To systematically review the available evidence on the incidence of optic neuritis reported in the cohort, its onset, linezolid doses and duration, spectrum, management approaches, and outcomes across case reports and series studies.Methods: A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines after registration in International Prospective Register of Systematic Reviews (PROSPERO; CRD420251108339). We searched PubMed, EMBASE, and Scopus. Eligible studies included case reports, case series, and cohort studies of patients with tuberculosis who developed optic neuritis while receiving linezolid. Data were extracted independently by two reviewers, and methodological quality was assessed using a validated tool for evaluating case reports and case series. Results were synthesized narratively with descriptive statistics.Results: Nineteen case reports and case series, 35 cohort studies, and safety data from five randomized controlled trials were included. Most reported cases originated from India (61.6%), with a mean age of 30.6±13.0 years; 65.4% were male. Linezolid was administered at 600 mg/day in nearly 90% of cases, with a median exposure of 7 months. Visual symptoms were typically painless and bilateral. After discontinuation of linezolid, more than half of the patients achieved complete visual recovery, while 34.6% experienced residual visual impairment. Across cohort studies, the incidence of optic neuritis ranged from 0.47% to 30%, with higher rates observed in smaller studies from a single country and among patients with a low body mass index.Conclusion: This infrequent but clinically significant complication requires early recognition, prompt drug withdrawal, and routine ophthalmological monitoring.
- 1 July 2026
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 89 (3) , 416-425
Open AccessLinezolid-Induced Optic Neuritis in Tuberculosis: A Systematic Review of Case Reports, Case Series, and Cohort Studies
Background: With the increasing use of linezolid for the treatment of drug-resistant tuberculosis, concerns have emerged regarding serious adverse effects, including optic neuritis. To systematically review the available evidence on the incidence of optic neuritis reported in the cohort, its onset, linezolid doses and duration, spectrum, management approaches, and outcomes across case reports and series studies.Methods: A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines after registration in International Prospective Register of Systematic Reviews (PROSPERO; CRD420251108339). We searched PubMed, EMBASE, and Scopus. Eligible studies included case reports, case series, and cohort studies of patients with tuberculosis who developed optic neuritis while receiving linezolid. Data were extracted independently by two reviewers, and methodological quality was assessed using a validated tool for evaluating case reports and case series. Results were synthesized narratively with descriptive statistics.Results: Nineteen case reports and case series, 35 cohort studies, and safety data from five randomized controlled trials were included. Most reported cases originated from India (61.6%), with a mean age of 30.6±13.0 years; 65.4% were male. Linezolid was administered at 600 mg/day in nearly 90% of cases, with a median exposure of 7 months. Visual symptoms were typically painless and bilateral. After discontinuation of linezolid, more than half of the patients achieved complete visual recovery, while 34.6% experienced residual visual impairment. Across cohort studies, the incidence of optic neuritis ranged from 0.47% to 30%, with higher rates observed in smaller studies from a single country and among patients with a low body mass index.Conclusion: This infrequent but clinically significant complication requires early recognition, prompt drug withdrawal, and routine ophthalmological monitoring.
- 3 June 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (11) , 2733-2741
Movement Disorders and Cerebellar Syndromes Associated with Mycoplasma pneumoniae Infection: A Systematic Review
Background: Mycoplasma pneumoniae is a well‐recognized respiratory pathogen increasingly associated with diverse neurological manifestations beyond pulmonary disease involvement. Objectives: To evaluate movement disorders and cerebellar syndromes linked to Mycoplasma pneumoniae, focusing on clinical relevance, diagnosis, and management challenges. Methods: A systematic review of published case reports and case series was conducted following PRISMA guidelines. Individual patient data were extracted for demographic characteristics, clinical features, diagnostic confirmation, cerebrospinal fluid findings, neuroimaging, treatment strategies, outcomes, and proposed pathophysiological mechanisms. The protocol was prospectively registered with PROSPERO under the identifier PROSPERO 2025 CRD420251243903. Results: A total of 42 published cases of Mycoplasma pneumoniae ‐associated movement disorders were analyzed. A preceding respiratory illness was documented in 69.0%, and neurological manifestations were mainly parainfectious (54.8%) or post‐infectious (28.6%). Cerebellar ataxia/cerebellitis (38.1%) and opsoclonus–myoclonus–ataxia syndrome (26.2%) were the most frequent phenotypes. Cerebrospinal fluid pleocytosis occurred in 54.8%, while neuroimaging was normal in 50.0%; abnormalities predominantly involved the cerebellum or basal ganglia. Antibiotics alone were used in 35.7%, and 45.3% received immunotherapy with or without antibiotics. Complete or near‐complete recovery occurred in 83.4%. Three pediatric cohorts confirmed the rarity of these disorders, with cerebellar ataxia as the universal phenotype and predominantly favorable outcomes. Conclusions: Movement disorders associated with or temporally related to Mycoplasma pneumoniae infection are uncommon and appear predominantly immune mediated , with cerebellar ataxia and opsoclonus–myoclonus–ataxia syndrome being the most frequent presentations. Most cases occur in a parainfectious or post‐infectious setting and show favorable outcomes with timely antibiotic and immunomodulatory therapy, although residual deficits may persist in a minority.
- 3 June 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (11) , 2733-2741
Movement Disorders and Cerebellar Syndromes Associated with Mycoplasma pneumoniae Infection: A Systematic Review
Background: Mycoplasma pneumoniae is a well‐recognized respiratory pathogen increasingly associated with diverse neurological manifestations beyond pulmonary disease involvement. Objectives: To evaluate movement disorders and cerebellar syndromes linked to Mycoplasma pneumoniae, focusing on clinical relevance, diagnosis, and management challenges. Methods: A systematic review of published case reports and case series was conducted following PRISMA guidelines. Individual patient data were extracted for demographic characteristics, clinical features, diagnostic confirmation, cerebrospinal fluid findings, neuroimaging, treatment strategies, outcomes, and proposed pathophysiological mechanisms. The protocol was prospectively registered with PROSPERO under the identifier PROSPERO 2025 CRD420251243903. Results: A total of 42 published cases of Mycoplasma pneumoniae ‐associated movement disorders were analyzed. A preceding respiratory illness was documented in 69.0%, and neurological manifestations were mainly parainfectious (54.8%) or post‐infectious (28.6%). Cerebellar ataxia/cerebellitis (38.1%) and opsoclonus–myoclonus–ataxia syndrome (26.2%) were the most frequent phenotypes. Cerebrospinal fluid pleocytosis occurred in 54.8%, while neuroimaging was normal in 50.0%; abnormalities predominantly involved the cerebellum or basal ganglia. Antibiotics alone were used in 35.7%, and 45.3% received immunotherapy with or without antibiotics. Complete or near‐complete recovery occurred in 83.4%. Three pediatric cohorts confirmed the rarity of these disorders, with cerebellar ataxia as the universal phenotype and predominantly favorable outcomes. Conclusions: Movement disorders associated with or temporally related to Mycoplasma pneumoniae infection are uncommon and appear predominantly immune mediated , with cerebellar ataxia and opsoclonus–myoclonus–ataxia syndrome being the most frequent presentations. Most cases occur in a parainfectious or post‐infectious setting and show favorable outcomes with timely antibiotic and immunomodulatory therapy, although residual deficits may persist in a minority.
- Open Access
- 25 May 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (5) , 359-360
High-flow Nasal Cannula Oxygen vs Non-invasive Ventilation with Passive Humidification: Are We Comparing Like with Like?
How to cite this article: Singhal S, Gurjar M. High-flow Nasal Cannula Oxygen vs Non-invasive Ventilation with Passive Humidification: Are We Comparing Like with Like? Indian J Crit Care Med 2026;30(5):359–360.
- 25 May 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (5) , 359-360
Open AccessHigh-flow Nasal Cannula Oxygen vs Non-invasive Ventilation with Passive Humidification: Are We Comparing Like with Like?
How to cite this article: Singhal S, Gurjar M. High-flow Nasal Cannula Oxygen vs Non-invasive Ventilation with Passive Humidification: Are We Comparing Like with Like? Indian J Crit Care Med 2026;30(5):359–360.
- 11 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-13
The neuroimaging spectrum of subacute sclerosing panencephalitis: a systematic review
Background We conducted a comprehensive analysis of spectrum of neuroimaging findings in Subacute Sclerosing Panencephalitis (SSPE) across case reports and cohort studies. Methods A systematic review was conducted as per PRISMA guidelines. Electronic databases were searched from inception using predefined terms related to SSPE and neuroimaging. Eligible studies included confirmed cases with reported imaging findings from case reports, case series, and cohort studies. Results Among 461 reported cases, neuroimaging was performed in 456 (98.9%), with MRI in 394 (85.5%) and CT in 58 (12.6%). White-matter abnormalities were identified in 431 (93.5%), most commonly diffuse bilateral (132, 28.6%), periventricular (104, 22.6%), subcortical (71, 15.4%), and posterior parieto-occipital-predominant patterns (63, 13.7%). Cortical involvement was present in 247 (53.6%), including diffuse hemispheric changes (74, 16.1%) and posterior predominance (68, 14.8%). Deep gray matter lesions occurred in 79 (17.2%), involving basal ganglia (47, 10.2%) and thalamus (23, 5.0%), while brainstem abnormalities were observed in 34 (7.4%). Diffusion restriction was reported in 52 (11.3%), contrast enhancement in 38 (8.2%), and cerebral atrophy in 162 (35.1%), including progressive atrophy in 63 (13.7%). Imaging mimics included ocular-first/visual pathway–predominant patterns (46, 10.0%), autoimmune encephalitis/ADEM-like patterns (37, 8.0%), leukodystrophy-like changes (31, 6.7%), stroke-like presentations (29, 6.3%), and basal ganglia–predominant forms (26, 5.6%). Conclusions Neuroimaging in SSPE shows predominant bilateral white matter involvement with posterior distribution, variable cortical and deep gray extension, progressive atrophy, limited enhancement, and frequent radiological mimics, reflecting a stage-evolving heterogeneous process.
- 11 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-13
The neuroimaging spectrum of subacute sclerosing panencephalitis: a systematic review
Background We conducted a comprehensive analysis of spectrum of neuroimaging findings in Subacute Sclerosing Panencephalitis (SSPE) across case reports and cohort studies. Methods A systematic review was conducted as per PRISMA guidelines. Electronic databases were searched from inception using predefined terms related to SSPE and neuroimaging. Eligible studies included confirmed cases with reported imaging findings from case reports, case series, and cohort studies. Results Among 461 reported cases, neuroimaging was performed in 456 (98.9%), with MRI in 394 (85.5%) and CT in 58 (12.6%). White-matter abnormalities were identified in 431 (93.5%), most commonly diffuse bilateral (132, 28.6%), periventricular (104, 22.6%), subcortical (71, 15.4%), and posterior parieto-occipital-predominant patterns (63, 13.7%). Cortical involvement was present in 247 (53.6%), including diffuse hemispheric changes (74, 16.1%) and posterior predominance (68, 14.8%). Deep gray matter lesions occurred in 79 (17.2%), involving basal ganglia (47, 10.2%) and thalamus (23, 5.0%), while brainstem abnormalities were observed in 34 (7.4%). Diffusion restriction was reported in 52 (11.3%), contrast enhancement in 38 (8.2%), and cerebral atrophy in 162 (35.1%), including progressive atrophy in 63 (13.7%). Imaging mimics included ocular-first/visual pathway–predominant patterns (46, 10.0%), autoimmune encephalitis/ADEM-like patterns (37, 8.0%), leukodystrophy-like changes (31, 6.7%), stroke-like presentations (29, 6.3%), and basal ganglia–predominant forms (26, 5.6%). Conclusions Neuroimaging in SSPE shows predominant bilateral white matter involvement with posterior distribution, variable cortical and deep gray extension, progressive atrophy, limited enhancement, and frequent radiological mimics, reflecting a stage-evolving heterogeneous process.
- Open Access
- 23 April 2026
- Published by South African Medical Association NPC in Southern African Journal of Critical Care
- Vol. 42 (1) , e4031
Incidence of nosocomial pneumonia and clinical outcomes of patients requiring non-invasive ventilation: A systematic review and meta-analysis
Background. Non-invasive ventilation (NIV) is used for an increasing range of clinical conditions at various levels of care, including intensive care units (ICUs), and has been shown to carry a lower risk of nosocomial pneumonia (NP) compared with invasive mechanical ventilation (IMV). Objectives. To assess the incidence of NP and clinical outcomes (intubation rates and mortality) in patients receiving NIV as initial support. Methods. A systematic search of PubMed, Embase and Scopus for relevant research articles published in English was conducted up to 6 February 2025. Eligible studies included adult patients who received NIV for any respiratory condition and reported the incidence of NP. NP was defined as any new-onset pneumonia occurring at any point during the clinical course and ≥48 hours after initiating NIV. Furthermore, a subset of patients in whom NP was attributed solely to NIV support was defined as NIV-associated pneumonia (NIVAP). Two reviewers independently conducted database searches, data extraction and risk-of-bias assessment. A subgroup analysis was performed based on the indication for NIV, country and study design to identify heterogeneity. Results. We incorporated 30 studies, including 36 049 patients receiving NIV. Of these, 29 studies reported the incidence of NP, while only 22 reported the incidence of NIVAP. Overall, the incidence of NP was 6% (95% confidence interval (CI) 4 - 8; I2=89.4%), and the pooled incidence of NIVAP was 3% (95% CI 2 - 4; I2=32.9%). The rate of intubation was 28% (95% CI 22 - 35; I2=89.3%), and overall mortality was 18% (95% CI 15 - 23; I2=99.0%) among patients receiving NIV. Conclusion. NP, including NIVAP, remains a significant complication in patients receiving NIV. Our findings underscore the need for standardised diagnostic criteria for NP in patients receiving NIV.
- 23 April 2026
- Published by South African Medical Association NPC in Southern African Journal of Critical Care
- Vol. 42 (1) , e4031
Open AccessIncidence of nosocomial pneumonia and clinical outcomes of patients requiring non-invasive ventilation: A systematic review and meta-analysis
Background. Non-invasive ventilation (NIV) is used for an increasing range of clinical conditions at various levels of care, including intensive care units (ICUs), and has been shown to carry a lower risk of nosocomial pneumonia (NP) compared with invasive mechanical ventilation (IMV). Objectives. To assess the incidence of NP and clinical outcomes (intubation rates and mortality) in patients receiving NIV as initial support. Methods. A systematic search of PubMed, Embase and Scopus for relevant research articles published in English was conducted up to 6 February 2025. Eligible studies included adult patients who received NIV for any respiratory condition and reported the incidence of NP. NP was defined as any new-onset pneumonia occurring at any point during the clinical course and ≥48 hours after initiating NIV. Furthermore, a subset of patients in whom NP was attributed solely to NIV support was defined as NIV-associated pneumonia (NIVAP). Two reviewers independently conducted database searches, data extraction and risk-of-bias assessment. A subgroup analysis was performed based on the indication for NIV, country and study design to identify heterogeneity. Results. We incorporated 30 studies, including 36 049 patients receiving NIV. Of these, 29 studies reported the incidence of NP, while only 22 reported the incidence of NIVAP. Overall, the incidence of NP was 6% (95% confidence interval (CI) 4 - 8; I2=89.4%), and the pooled incidence of NIVAP was 3% (95% CI 2 - 4; I2=32.9%). The rate of intubation was 28% (95% CI 22 - 35; I2=89.3%), and overall mortality was 18% (95% CI 15 - 23; I2=99.0%) among patients receiving NIV. Conclusion. NP, including NIVAP, remains a significant complication in patients receiving NIV. Our findings underscore the need for standardised diagnostic criteria for NP in patients receiving NIV.
- Open Access
- 31 March 2026
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 16, 22
Movement Disorders in Scrub Typhus: A Systematic Review
Background: Scrub typhus is a major rickettsial infection in Asia, occasionally presenting with movement disorders due to central nervous system involvement. This systematic review aimed to summarize their frequency, spectrum, diagnostic profile, treatment, and outcomes. Methods: A comprehensive search of PubMed, Embase, Scopus, and Google Scholar was conducted up to August 2025. All case reports, case series, and cohort studies reporting movement disorders associated with scrub typhus were included. Data were extracted and analyzed descriptively. The protocol was prospectively registered with PROSPERO under the identifier PROSPERO 2025 CRD420251156525. Results: Across 55 published cases, scrub typhus–associated movement disorders occurred predominantly in young adults (median age 28 years), with a male predominance (61.8%). Opsoclonus and related ocular motor disorders were the most frequent manifestations (41.8%), followed by cerebellar syndromes (34.5%), parkinsonism (12.7%), myoclonus (7.3%), and rare presentations such as ballismus, dystonia, opisthotonus, and akinetic mutism (7.3%). Associated neurological signs included cerebellar involvement (32.7%), altered sensorium (25.5%), extrapyramidal features (21.8%), and seizures (10.9%). In cohort studies including 2437 patients, 63 (2.6%) developed movement disorders, with opsoclonus–myoclonus seen in 22 (34.9%), ataxia in 17, myoclonus in 11 (17.4%), and extrapyramidal features in 25 (39.6%). Rare hyperkinetic manifestations such as hemiballismus and choreoathetoid movements were occasionally reported. Most patients had favorable outcomes, with complete recovery in 38 (69.1%), near-complete recovery in 6 (10.9%), partial recovery in 5 (9.1%), and death in 1 (1.8%). Conclusions: Movement disorders in scrub typhus, though uncommon, display a wide clinical spectrum and are often reversible.
- 31 March 2026
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 16, 22
Open AccessMovement Disorders in Scrub Typhus: A Systematic Review
Background: Scrub typhus is a major rickettsial infection in Asia, occasionally presenting with movement disorders due to central nervous system involvement. This systematic review aimed to summarize their frequency, spectrum, diagnostic profile, treatment, and outcomes. Methods: A comprehensive search of PubMed, Embase, Scopus, and Google Scholar was conducted up to August 2025. All case reports, case series, and cohort studies reporting movement disorders associated with scrub typhus were included. Data were extracted and analyzed descriptively. The protocol was prospectively registered with PROSPERO under the identifier PROSPERO 2025 CRD420251156525. Results: Across 55 published cases, scrub typhus–associated movement disorders occurred predominantly in young adults (median age 28 years), with a male predominance (61.8%). Opsoclonus and related ocular motor disorders were the most frequent manifestations (41.8%), followed by cerebellar syndromes (34.5%), parkinsonism (12.7%), myoclonus (7.3%), and rare presentations such as ballismus, dystonia, opisthotonus, and akinetic mutism (7.3%). Associated neurological signs included cerebellar involvement (32.7%), altered sensorium (25.5%), extrapyramidal features (21.8%), and seizures (10.9%). In cohort studies including 2437 patients, 63 (2.6%) developed movement disorders, with opsoclonus–myoclonus seen in 22 (34.9%), ataxia in 17, myoclonus in 11 (17.4%), and extrapyramidal features in 25 (39.6%). Rare hyperkinetic manifestations such as hemiballismus and choreoathetoid movements were occasionally reported. Most patients had favorable outcomes, with complete recovery in 38 (69.1%), near-complete recovery in 6 (10.9%), partial recovery in 5 (9.1%), and death in 1 (1.8%). Conclusions: Movement disorders in scrub typhus, though uncommon, display a wide clinical spectrum and are often reversible.